Template:IHC of MMR
(Perform immunohistochemistry for MLH-1, PMS-2, MSH-2 and MSH-6.) They are scored as:[1]
0% nuclear expression in tumor cell nuclei: Loss of expression (expression seen in stromal cells in image)
More than 0% but less than 10%: Indeterminate expression
10% or more: Retained expression
Contents
Notes
Main page
References
- ↑ These cutoffs are used for both colorectal and endometrial cancers:
- Sarode, Venetia R.; Robinson, Linda (2019). "Screening for Lynch Syndrome by Immunohistochemistry of Mismatch Repair Proteins: Significance of Indeterminate Result and Correlation With Mutational Studies ". Archives of Pathology & Laboratory Medicine 143 (10): 1225–1233. doi:. ISSN 0003-9985.
- Sarode VR, Robinson L (2019). "Screening for Lynch Syndrome by Immunohistochemistry of Mismatch Repair Proteins: Significance of Indeterminate Result and Correlation With Mutational Studies. ". Arch Pathol Lab Med 143 (10): 1225-1233. doi:. PMID 30917047. Archived from the original. .
- Lee JHS, Li JJX, Chow C, Chan RCK, Kwan JSH, Lau TS (2021). "Long-Term Survival and Clinicopathological Implications of DNA Mismatch Repair Status in Endometrioid Endometrial Cancers in Hong Kong Chinese Women. ". Biomedicines 9 (10). doi:. PMID 34680502. PMC: 8533409. Archived from the original. .
Image sources
